[Featured Stock] Andyforce Appoints Nobel Chemistry Laureate as Internal Director... "Accelerating COVID-19 Treatment Development"

[Asia Economy Reporter Jang Hyowon] AndyForce's stock price is soaring. The appointment of Nobel Chemistry laureate Professor Roger Kornberg as an inside director and the acceleration of developing a treatment for COVID-19 appear to have influenced the stock price.

As of 10:45 AM on the 27th, AndyForce is trading at 3,600 KRW, up 17.26% (530 KRW) compared to the previous day.

On the same day, AndyForce announced that it would grant Professor Roger Kornberg stock options amounting to 2% (1 million shares) of the total issued shares. AndyForce plans to grant stock options and focus all its capabilities on new drug development projects with Professor Roger Kornberg.

Professor Roger Kornberg discovered various enzyme proteins involved in the transcription process, a biomedical process that regulates most human gene expression. He also elucidated the structure of the transcription-related protein complex at the atomic level, for which he was awarded the Nobel Prize in Chemistry. With the outbreak of COVID-19, he has been working with members of the World Laureates Association (WLA) to develop treatments for the COVID-19 virus.

An AndyForce official explained, "Typically, granting stock options means providing incentives to retain key personnel long-term," adding, "By granting stock options to Professor Roger Kornberg, AndyForce can create long-term synergy with key personnel in the new drug development business."

They continued, "Since we recently started developing treatments for viral infections such as lung cancer and COVID-19 based on siRNA technology as a new pipeline, we expect even greater synergy with Professor Roger Kornberg."

This content was produced with the assistance of AI translation services.